Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Hyperlipidemia
by Highest Patent Value in the world in 2019

The Hyperlipidemia top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Hyperlipidemia Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
#
Company Name
Region
Tech Topics
Total
1
United Kingdom
Gastrointestinal agent,Health care,Niquitin,
...[+2]
Avg patent value: 4.04 M
2
Noord-Holland, Netherlands
Avg patent value: 3.22 M
3
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 2.76 M
4
Hokkaido, Japan
Photonics,Health care,Lifestyle business,
...[+1]
Avg patent value: 1.07 M
5
Shandong Sheng, China
Avg patent value: 490,000
6
Västra Götaland, Sweden
Avg patent value: 490,000
7
Medicine,Medical equipment,Health care,
...[+2]
Avg patent value: 450,000
8
Kanagawa, Japan
Health care,Patiromer,Cardiovascular agent,
...[+2]
Avg patent value: 210,000
9
Arkay Therapeutics LLC
Diabetes Therapy,Health care
Avg patent value: 88,000
10
Epirium
Mitochondrial biogenesis,Biology,Health care,
...[+2]
Avg patent value: 28,000
Page generation time: May 21 2025